CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale See remarks sold 80,909 shares at an average $6.70 ($542,448)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale See remarks sold 1,345 shares at $6.38 ($8,581)
- 4 Open-market sale Chief Legal Officer sold 1,623 shares at $6.38 ($10,355)
- 4 Open-market sale Chief Financial Officer sold 1,695 shares at $6.38 ($10,814)
- 4 Open-market sale President, R&D sold 2,686 shares at $6.38 ($17,137)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 348 shares at $7.70 ($2,680)
- 4 Open-market sale President, R&D sold 765 shares at $7.70 ($5,891)
Page 12 of 28 · 556 filings